Caricamento...
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
The prognosis of patients with acute myeloid leukemia (AML) remains dismal, highlighting the need for novel innovative treatment strategies. The application of chimeric antigen receptor (CAR) T-cell therapy to patients with AML has been limited, in particular by the lack of a tumor-specific target a...
Salvato in:
| Pubblicato in: | Blood |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8323977/ https://ncbi.nlm.nih.gov/pubmed/34323938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020008221 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|